Modulations of NeuroD activity contribute to the differential effects of morphine and fentanyl on dendritic spine stability - PubMed (original) (raw)
Modulations of NeuroD activity contribute to the differential effects of morphine and fentanyl on dendritic spine stability
Hui Zheng et al. J Neurosci. 2010.
Abstract
The cellular level of neurogenic differentiation 1 (NeuroD) is modulated differentially by mu-opioid receptor agonists; fentanyl increases NeuroD level by reducing the amount of microRNA-190 (miR-190), an inhibitor of NeuroD expression, whereas morphine does not alter NeuroD level. In the current study, NeuroD activity was demonstrated to be also under agonist-dependent regulation. After 3 d of treatment, morphine and fentanyl decreased the activity of the Ca(2+)/calmodulin-dependent protein kinase II alpha (CaMKIIalpha), which phosphorylates and activates NeuroD. Because NeuroD activity is determined by both the CaMKIIalpha activity and the cellular NeuroD level, the overall NeuroD activity was reduced by morphine, but maintained during fentanyl treatment. The differential effects of agonists on NeuroD activity were further confirmed by measuring the mRNA levels of four NeuroD downstream targets: doublecortin, Notch1, neurogenic differentiation 4, and Roundabout 1. Decreased dendritic spine stability and mu-opioid receptor signaling capability were also observed when NeuroD activity was attenuated by miR-190 overexpression or treatment with KN93, a CaMKIIalpha inhibitor. The decrease could be rescued by NeuroD overexpression, which restored NeuroD activity to the basal level. Furthermore, elevating NeuroD activity attenuated the morphine-induced decrease in dendritic spine stability. Therefore, by regulating NeuroD activity, mu-opioid receptor agonists modulate the stability of dendritic spines.
Figures
Figure 1.
Morphine, but not fentanyl, decreases NeuroD activity. Primary rat hippocampal cultures were treated with PBS (control), 1 μ
m
morphine, or 10 n
m
fentanyl for 3 d. A, The amount of phosphorylated serine was determined in immunoprecipitated NeuroD to indicate NeuroD phosphorylation (pND). Total NeuroD (ND) was measured in the nuclear extracts. The total CaMKIIα (CaM), phosphorylated CaMKIIα (pCaM), total ERK, and β-actin were detected in whole-cell lysis. Total ERK and β-actin served as internal controls. IP, Immunoprecipitation; IB, immunoblotting. B, The levels of miR-190 and NeuroD mRNA were measured by real-time PCR. C, mRNA levels of DCX, ND4, Notch1, and Robo1 were determined by real-time PCR. A–C, Results were normalized against those in control samples. Error bars indicate SD. *p < 0.05.
Figure 2.
NeuroD level correlates with its activity. Primary cultures were treated with PBS (control), con-vir, 190-vir, 190-vir plus nd-vir, and nd-vir for 3 d. A, The amounts of phosphorylated NeuroD (pND), total NeuroD (ND), total CaMKIIα (CaM), phosphorylated CaMKIIα (pCaM), total ERK, and β-actin were determined as in Figure 1_A_. B, The levels of miR-190 and NeuroD mRNA were measured by real-time PCR. C, The mRNA levels of DCX, ND4, Notch1, and Robo1 were determined with real-time PCR. A–C, Results were normalized against those in control samples. IP, Immunoprecipitation; IB, immunoblotting. Error bars indicate SD. *p < 0.05.
Figure 3.
NeuroD activity correlates with its phosphorylation by CaMKIIα. Primary cultures were treated with PBS (control), KN92 (2 μ
m
), KN93 (2 μ
m
), or KN93 (2 μ
m
) plus nd-vir for 3 d. A, The amount of phosphorylated NeuroD (pND), total NeuroD (ND), total CaMKIIα (CaM), phosphorylated CaMKIIα (pCaM), total ERK, and β-actin were determined as in Figure 1_A_. B, The levels of miR-190 and NeuroD mRNA were measured by real-time PCR. C, The mRNA levels of DCX, ND4, Notch1, and Robo1 were determined with real-time PCR. A–C, Results were normalized against those in control samples. IP, Immunoprecipitation; IB, immunoblotting. Error bars indicate SD. *p < 0.05.
Figure 4.
Spine collapse and new spine formation during control PBS treatment. Primary cultures from rat hippocampal neurons were treated with PBS (control) for 3 d. A, B, Live-cell images on day 0 (A) and day 3 (B) of a representative neuron were presented. Spine densities on day 0 and day 3, the numbers of newly formed spines, and the number of spines that collapsed, shrank, or enlarged during 3 d are also summarized in C. Error bars indicate SD.
Figure 5.
NeuroD activity is required to maintain spine stability. Primary cultures were treated with PBS (control), con-vir, 190-vir, 190-vir plus nd-vir, nd-vir, KN92 (2 μ
m
), KN93 (2 μ
m
), or KN93 (2 μ
m
) plus nd-vir for 3 d. A, Live-cell images of a portion of a single dendrite from a representative neuron on day 0 and day 3. EGFP and ECFP were used to indicate successful infection of con-vir/190-vir and nd-vir, respectively. Stars indicate the spines' decrease in size. B, Spine densities on day 0 and day 3 were quantified. C, Spine volumes were calculated by the overall DsRed fluorescence and the fluorescence intensity on day 3 was normalized against that on day 0. D, he apoptosis rates were also determined, with neurons treated with 1 μ
m
staurosporin for 24 h serving as positive control. Error bars indicate SD. *p < 0.05.
Figure 6.
Overexpressing NeuroD counteracts morphine-induced decrease in NeuroD activity. Primary cultures were treated with PBS, morphine (1 μ
m
), morphine (1 μ
m
) plus nd-vir, fentanyl (10 n
m
), fentanyl (10 n
m
) plus 190-vir, or fentanyl (10 n
m
) plus KN93 for 3 d. A, The amount of phosphorylated NeuroD (pNeuroD), total NeuroD, total CaMKIIα (CaM), phosphorylated CaMKIIα (pCaM), total ERK, and β-actin were determined as in Figure 1_A_. B, The levels of miR-190 and NeuroD (ND) mRNA were measured by real-time PCR. IP, Immunoprecipitation; IB, immunoblotting. C, The mRNA levels of DCX, ND4, Notch1, and Robo1 were determined by real-time PCR. A–C, Results were normalized against those in control samples. Error bars indicate SD. *p < 0.05.
Figure 7.
Elevating NeuroD activity attenuates morphine-induced decrease in spine stability. Primary hippocampal neuron cultures were treated with PBS (control), DMSO (0.1%), morphine (1 μ
m
), morphine (1 μ
m
) plus nd-vir, fentanyl (10 n
m
), fentanyl (10 n
m
) plus 190-vir, or fentanyl (10 n
m
) plus KN93 for 3 d. A, Live-cell images of a portion of a dendrite from a representative neuron on day 0 and day 3. Stars indicate the spines' decrease in size. B, Spine densities on day 0 and day 3. C, Spine volumes were measured by the overall DsRed fluorescence, and the fluorescence intensity on day 3 was normalized against that on day 0. D, Apoptosis rates were measured as in Figure 5_D_. Error bars indicate SD. *p < 0.05.
Figure 8.
Schematic summary of agonist-dependent regulation on NeuroD activity.
Similar articles
- mu-Opioid receptor agonists differentially regulate the expression of miR-190 and NeuroD.
Zheng H, Zeng Y, Zhang X, Chu J, Loh HH, Law PY. Zheng H, et al. Mol Pharmacol. 2010 Jan;77(1):102-9. doi: 10.1124/mol.109.060848. Epub 2009 Oct 23. Mol Pharmacol. 2010. PMID: 19854889 Free PMC article. - NeuroD modulates opioid agonist-selective regulation of adult neurogenesis and contextual memory extinction.
Zheng H, Zhang Y, Li W, Loh HH, Law PY. Zheng H, et al. Neuropsychopharmacology. 2013 Apr;38(5):770-7. doi: 10.1038/npp.2012.242. Epub 2012 Nov 29. Neuropsychopharmacology. 2013. PMID: 23303051 Free PMC article. - Yin Yang 1 phosphorylation contributes to the differential effects of mu-opioid receptor agonists on microRNA-190 expression.
Zheng H, Chu J, Zeng Y, Loh HH, Law PY. Zheng H, et al. J Biol Chem. 2010 Jul 16;285(29):21994-2002. doi: 10.1074/jbc.M110.112607. Epub 2010 May 10. J Biol Chem. 2010. PMID: 20457614 Free PMC article. - Bidirectional effects of fentanyl on dendritic spines and AMPA receptors depend upon the internalization of mu opioid receptors.
Lin H, Higgins P, Loh HH, Law PY, Liao D. Lin H, et al. Neuropsychopharmacology. 2009 Aug;34(9):2097-111. doi: 10.1038/npp.2009.34. Epub 2009 Mar 18. Neuropsychopharmacology. 2009. PMID: 19295508 Free PMC article. - Modulating micro-opioid receptor phosphorylation switches agonist-dependent signaling as reflected in PKCepsilon activation and dendritic spine stability.
Zheng H, Chu J, Zhang Y, Loh HH, Law PY. Zheng H, et al. J Biol Chem. 2011 Apr 8;286(14):12724-33. doi: 10.1074/jbc.M110.177089. Epub 2011 Feb 3. J Biol Chem. 2011. PMID: 21292762 Free PMC article.
Cited by
- miRNAs and Substances Abuse: Clinical and Forensic Pathological Implications: A Systematic Review.
Occhipinti C, La Russa R, Iacoponi N, Lazzari J, Costantino A, Di Fazio N, Del Duca F, Maiese A, Fineschi V. Occhipinti C, et al. Int J Mol Sci. 2023 Dec 4;24(23):17122. doi: 10.3390/ijms242317122. Int J Mol Sci. 2023. PMID: 38069445 Free PMC article. Review. - MiR-33-5p Regulates CREB to Induce Morphine State-dependent Memory in Rats: Interaction with the µ Opioid Receptor.
Moradi Vastegani S, Alani B, Kharazmi K, Ardjmand A. Moradi Vastegani S, et al. Int J Mol Cell Med. 2022;11(2):150-167. doi: 10.22088/IJMCM.BUMS.11.2.150. Epub 2023 Feb 1. Int J Mol Cell Med. 2022. PMID: 37091037 Free PMC article. - Orbitofrontal cortex microRNAs support long-lasting heroin seeking behavior in male rats.
Zanda MT, Floris G, Daws SE. Zanda MT, et al. Transl Psychiatry. 2023 Apr 8;13(1):117. doi: 10.1038/s41398-023-02423-4. Transl Psychiatry. 2023. PMID: 37031193 Free PMC article. - HIV-1 Tat reduces apical dendritic spine density throughout the trisynaptic pathway in the hippocampus of male transgenic mice.
McLane VD, Lark ARS, Nass SR, Knapp PE, Hauser KF. McLane VD, et al. Neurosci Lett. 2022 Jun 21;782:136688. doi: 10.1016/j.neulet.2022.136688. Epub 2022 May 17. Neurosci Lett. 2022. PMID: 35595189 Free PMC article. - microRNA expression levels in the nucleus accumbens correlate with morphine-taking but not morphine-seeking behaviour in male rats.
Gillespie A, Mayberry HL, Wimmer ME, Sillivan SE. Gillespie A, et al. Eur J Neurosci. 2022 Apr;55(7):1742-1755. doi: 10.1111/ejn.15650. Epub 2022 Mar 29. Eur J Neurosci. 2022. PMID: 35320877 Free PMC article.
References
- Bao G, Kang L, Li H, Li Y, Pu L, Xia P, Ma L, Pei G. Morphine and heroin differentially modulate in vivo hippocampal LTP in opiate-dependent rat. Neuropsychopharmacology. 2007;32:1738–1749. - PubMed
- Chae JH, Stein GH, Lee JE. NeuroD: the predicted and the surprising. Mol Cells. 2004;18:271–288. - PubMed
- Cho JH, Tsai MJ. The role of BETA2/NeuroD1 in the development of the nervous system. Mol Neurobiol. 2004;30:35–47. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- DA007339/DA/NIDA NIH HHS/United States
- K05 DA000513/DA/NIDA NIH HHS/United States
- P50 DA011806-10/DA/NIDA NIH HHS/United States
- R56 DA000564/DA/NIDA NIH HHS/United States
- R01 DA000564-37/DA/NIDA NIH HHS/United States
- R01 DA007339-18/DA/NIDA NIH HHS/United States
- K05-DA00513/DA/NIDA NIH HHS/United States
- R01 DA001583/DA/NIDA NIH HHS/United States
- R01 DA023905-03/DA/NIDA NIH HHS/United States
- K05 DA070554/DA/NIDA NIH HHS/United States
- K05 DA000513-10/DA/NIDA NIH HHS/United States
- DA016674/DA/NIDA NIH HHS/United States
- K05 DA070554-36/DA/NIDA NIH HHS/United States
- R01 DA001583-33/DA/NIDA NIH HHS/United States
- R01 DA016674/DA/NIDA NIH HHS/United States
- R01 DA023905/DA/NIDA NIH HHS/United States
- DA011806/DA/NIDA NIH HHS/United States
- DA000564/DA/NIDA NIH HHS/United States
- R01 DA000564/DA/NIDA NIH HHS/United States
- K05-DA70544/DA/NIDA NIH HHS/United States
- P50 DA011806/DA/NIDA NIH HHS/United States
- R01 DA007339/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous